Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses

Behavioral and Brain Functions

Volumn 8, Issue , 2012, Pages

  Zhang, Huiping ^a,b   Wang, Fan ^a,b   Kranzler, Henry R ^c   Anton, Raymond F ^d   Gelernter, Joel ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Genetic association; Genotype expression relationship; Haplotype analysis; Multiple substance dependence; Regression analysis; Rgs17 and rgs20

Indexed keywords

RGS PROTEIN; RGS17 PROTEIN; RGS20 PROTEIN; UNCLASSIFIED DRUG; RGS17 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ALCOHOLISM; ALLELE; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ADDICTION; CAUCASIAN; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HAPLOTYPE; METABOLISM; MIDDLE AGED; OPIATE ADDICTION; RISK FACTOR; SIGNAL TRANSDUCTION; STATISTICS; UNITED STATES;

ADULT; AFRICAN AMERICANS; ALCOHOLISM; COCAINE-RELATED DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MARIJUANA ABUSE; MIDDLE AGED; OPIOID-RELATED DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; RGS PROTEINS; RISK FACTORS; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84861000037     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-8-23     Document Type: Article

References (45)

1. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998, 55(11):967-972. 10.1001/archpsyc.55.11.967, 9819064.
2. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003, 160(4):687-695. 10.1176/appi.ajp.160.4.687, 12668357.
3. Lachman HM. An overview of the genetics of substance use disorders. Curr Psychiatry Rep 2006, 8(2):133-143. 10.1007/s11920-006-0013-3, 16539891.
4. Li MD, Burmeister M. New insights into the genetics of addiction. Nat Rev Genet 2009, 10(4):225-231. 10.1038/nrg2536, 2879628, 19238175.
5. De Vries L, Zheng B, Fischer T, Elenko E, Farquhar MG. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 2000, 40:235-271. 10.1146/annurev.pharmtox.40.1.235, 10836135.
6. Sierra DA, Gilbert DJ, Householder D, Grishin NV, Yu K, Ukidwe P, Barker SA, He W, Wensel TG, Otero G, Brown G, Copeland NG, Jenkins NA, Wilkie TM. Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics 2002, 79(2):177-185. 10.1006/geno.2002.6693, 11829488.
7. Ross EM, Wilkie TM. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000, 69:795-827. 10.1146/annurev.biochem.69.1.795, 10966476.
8. Elenko E, Fischer T, Niesman I, Harding T, McQuistan T, Von Zastrow M, Farquhar MG. Spatial regulation of Galphai protein signaling in clathrin-coated membrane microdomains containing GAIP. Mol Pharmacol 2003, 64(1):11-20. 10.1124/mol.64.1.11, 12815156.
9. Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, Myers RM. An abundance of bidirectional promoters in the human genome. Genome Res 2004, 14(1):62-66. 314279, 14707170.
10. Garzon J, Rodriguez-Munoz M, Lopez-Fando A, Sanchez-Blazquez P. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins. Neuropsychopharmacology 2005, 30(9):1632-1648. 10.1038/sj.npp.1300726, 15827571.
11. Ajit SK, Ramineni S, Edris W, Hunt RA, Hum WT, Hepler JR, Young KH. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling. Cell Signal 2007, 19(4):723-730. 10.1016/j.cellsig.2006.09.008, 17126529.
12. Garzon J, Rodriguez-Munoz M, Lopez-Fando A, Garcia-Espana A, Sanchez-Blazquez P. RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology 2004, 29(6):1091-1104. 10.1038/sj.npp.1300408, 14997173.
13. Town T, Abdullah L, Crawford F, Schinka J, Ordorica PI, Francis E, Hughes P, Duara R, Mullan M. Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet 1999, 88(5):458-461. 10.1002/(SICI)1096-8628(19991015)88:5<458::AID-AJMG3>3.0.CO;2-S, 10490697.
14. Schinka JA, Town T, Abdullah L, Crawford FC, Ordorica PI, Francis E, Hughes P, Graves AB, Mortimer JA, Mullan M. A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry 2002, 7(2):224-228. 10.1038/sj.mp.4000951, 11840318.
15. Kim SG, Kim CM, Kang DH, Kim YJ, Byun WT, Kim SY, Park JM, Kim MJ, Oslin DW. Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcohol Clin Exp Res 2004, 28(7):986-990. 10.1097/01.ALC.0000130803.62768.AB, 15252283.
16. Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig M. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 2005, 30(2):417-422. 10.1038/sj.npp.1300598, 15525999.
17. Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E, Zvartau E, Gelernter J. Association between two {micro}-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 2006, 15(6):807-819. 10.1093/hmg/ddl024, 3164878, 16476706.
18. Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, Bierut L, Goate A, Bucholz K, Schuckit M, Nurnberger J, Tischfield J, Kuperman S, Porjesz B, Begleiter H, Foroud T, Edenberg HJ. Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 2006, 11(11):1016-1024. 10.1038/sj.mp.4001882, 16924269.
19. Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 2008, 13(5):531-543. 10.1038/sj.mp.4002035, 3163084, 17622222.
20. Franke P, Wang T, Nöthen MM, Knapp M, Neidt H, Albrecht S, Jahnes E, Propping P, Maier W. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet 2001, 105(1):114-119. 10.1002/1096-8628(20010108)105:1<114::AID-AJMG1074>3.0.CO;2-L, 11424981.
21. Doyle GA, Furlong PJ, Schwebel CL, Smith GG, Lohoff FW, Buono RJ, Berrettini WH, Ferraro TN. Fine mapping of a major QTL influencing morphine preference in C57BL/6 and DBA/2 mice using congenic strains. Neuropsychopharmacology 2008, 33(12):2801-2809. 10.1038/npp.2008.14, 18288093.
22. Vadasz C, Saito M, Gyetvai B, Mikics E, Vadasz C. Scanning of five chromosomes for alcohol consumption loci. Alcohol 2000, 22(1):25-34. 10.1016/S0741-8329(00)00098-7, 11109025.
23. Yalcin B, Willis-Owen SA, Fullerton J, Meesaq A, Deacon RM, Rawlins JN, Copley RR, Morris AP, Flint J, Mott R. Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. Nat Genet 2004, 36(11):1197-1202. 10.1038/ng1450, 15489855.
24. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J, Franke P, Bandelow B, Fimmers R, Flint J, Deckert J. Rgs 2 gene polymorphisms as modulators of anxiety in humans?. J Neural Transm 2006, 113(12):1921-1925. 10.1007/s00702-006-0484-8, 16736243.
25. Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, Egan MF, Gill M, Kendler KS, Kirov G, Heston LL, Levitt P, Lewis DA, Li T, Mirnics K, Morris DW, Norton N, O'Donovan MC, Owen MJ, Richard C, Semwal P, Sobell JL, St Clair D, Straub RE, Thelma BK, Vallada H, et al. Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 2006, 60(2):152-162. 10.1016/j.biopsych.2006.02.015, 3133764, 16631129.
26. Li D, He L. Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis. Eur J Hum Genet 2006, 14(10):1130-1135. 10.1038/sj.ejhg.5201680, 16791139.
27. Pierucci-Lagha A, Gelernter J, Feinn R, Cubells JF, Pearson D, Pollastri A, Farrer L, Kranzler HR. Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Depend 2005, 80(3):303-312. 10.1016/j.drugalcdep.2005.04.005, 15896927.
28. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders , Washington DC, 4, American Psychiatric Association.
29. Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA. High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. Mol Pathol 1999, 52(5):295-299. 10.1136/mp.52.5.295, 395713, 10748880.
30. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155(2):945-959. 1461096, 10835412.
31. Yang BZ, Zhao H, Kranzler HR, Gelernter J. Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol 2005, 28(4):302-312. 10.1002/gepi.20070, 15782414.
32. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, Weiss RD, Farrer L, Gelernter J. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry 2009, 66(11):1201-1209. 10.1001/archgenpsychiatry.2009.153, 2867334, 19884608.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575. 10.1086/519795, 1950838, 17701901.
34. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
35. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229. 10.1126/science.1069424, 12029063.
36. Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Yazaki Y, Shibata Y, Hirai H. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms. Leukemia 1997, 11(Suppl 3):299-302.
37. Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J 1995, 14(2):341-350. 398088, 7530657.
38. Niitsu N, Yamamoto-Yamaguchi Y, Miyoshi H, Shimizu K, Ohki M, Umeda M, Honma Y. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth Differ 1997, 8(3):319-326.
39. Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by kappa opiate receptors. Science 1986, 233(4765):774-776. 10.1126/science.3016896, 3016896.
40. Maher B. Personal genomes: The case of the missing heritability. Nature 2008, 456(7218):18-21. 10.1038/456018a, 18987709.
41. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P, Fitzgerald T, Hu M, Ihm CH, Kristiansson K, Macarthur DG, Macdonald JR, Onyiah I, Pang AW, Robson S, Stirrups K, Valsesia A, Walter K, Wei J, Wellcome Trust Case Control C, Tyler-Smith C, Carter NP, Lee C, Scherer SW, Hurles ME. Origins and functional impact of copy number variation in the human genome. Nature 2010, 464(7289):704-712. 10.1038/nature08516, 3330748, 19812545.
42. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet 2005, 6(7):521-532.
43. Nielsen DA, Yuferov V, Hamon S, Jackson C, Ho A, Ott J, Kreek MJ. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 2009, 34(4):867-873. 10.1038/npp.2008.108, 2778040, 18650805.
44. Hillemacher T. Biological mechanisms in alcohol dependence-new perspectives. Alcohol Alcohol 2011, 46(3):224-230.
45. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res 2004, 122(1):24-34.